Search for: "Ortho McNeil Pharmaceutical, Inc."
Results 1 - 20 of 67
Sorted by Relevance | Sort by Date
9 Apr, 2008 8:49 pm
By Donald Zuhn -- Last week, the Federal Circuit issued an opinion in Ortho-McNeil
Pharmaceutical, Inc. v. Mylan Laboratories, Inc. In Mylan Laboratories, the Federal Circuit determined that the District Court for the District of New Jersey
properly construed claim 1 of U.S. Patent No. 4,513,006, owned by Plaintiff-Appellee Ortho-McNeil...
26 Aug 9:59 pm
... the District Court for the District of New Jersey granting summary judgment of invalidity of U.S. Reissued Patent No. 39,221 based on anticipation and obviousness.
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which
relates to a tramadol and acetaminophen composition for use in prescription pain relief. Ortho first claimed this composition in U.S. Patent
No. 5,336,691, and after receiving FDA approval, began marketing ...
6 Apr, 2008 9:15 pm
By Donald Zuhn -- Last week, the Federal Circuit determined that the District Court for the District of New Jersey properly construed claim 1 of U.S. Patent No. 4,513,006 to encompass
Plaintiff-Appellee Ortho-McNeil Pharmaceutical, Inc.'s epilepsy drug topiramate, and
affirmed the District Court's decision to (1) permanently enjoin Defendants-Appellees Mylan...
10 Jun 9:02 pm
... for the Northern District of West Virginia awarding $1,011,712 in costs to Plaintiff-Appellee Daiichi Pharmaceutical Co., and remanded to the District Court for an
apportionment determination of the awarded costs. Daiichi owns U.S. Patent No. ... name Levaquin®. Seeking approval to market a generic version of levofloxacin, Defendants-Appellants
Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. In response to Mylan's ANDA filing,...
22 Jan, 2007 6:39 pm
Intrinsic Evidence Pointing to a Criticality of a Claimed Ratio Used to Construe the Term "About." (Fed. Cir. 2007, 06-1102) Caraco filed an ANDA with the intent to make and sell a
pharmaceutical composition containing tramadol and acetaminophen with an average weight ratio of tramadol to acetaminophen of 1:8.67, and no less than a ratio of 1:7.5. In
response, Ortho [...]
21 Jan, 2007 8:53 pm
... the '691 patent, which recites (when read in conjunction with the two claims on which it depends): "A pharmaceutical composition comprising a tramadol material and
acetaminophen, wherein the ratio of the tramadol material to ... patent validity and enforceability decisions in Ortho-McNeil's corresponding Ultracet ANDA litigations against Kali Laboratories, Inc. (a Par Pharmaceutical subsidiary), No. 02-CV-5707-JCL-MF (D.
N.J.), and Teva Pharmaceutical Industries, Ltd., No. 04-CV-886-HAA-GDH (D. N.J ...
23 Jul, 2007 9:13 pm
By Sherri Oslick -- Ortho-McNeil, Inc. announced late last week that it has settled its
lawsuit against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc. and Kali Laboratories, Inc., over the patent
covering Ortho's Ultracet® (tramadol hydrochloride and acetaminophen, used to treat acute pain). As part of the...
19 Mar, 2007 12:05 pm
... . The Ortho Evra birth control patch (known more familiarly as "the Patch") was introduced on the market in 2002 by Ortho McNeil Pharmaceutical Inc., a division of Johnson & Johnson, as an alternative to the birth
control pill. The Patch was marketed as being ... . Members of Burg Simpson served on discovery committee. $60,000,000: Global settlement involving defective pharmaceutical
product. Members of Burg Simpson served on discovery committee. $25,000,000: Confidential settlements for clients ...
18 Oct, 2006 6:23 pm
... to the nature, extent, and number, of patients who have sustained serious personal injury and even death as the result of use of Ortho
Evra.). The likely reasons for the rapid settlements are twofold and clear: (1) the manufacturer (Johnson & Johnson, a division of Ortho-McNeil Pharmaceutical Inc) wants to keep a lid on things by requiring 'confidentiality'; and (2)
the causal relationship between the injuries and the product are ...
25 Aug, 2006 6:55 pm
A law suit has been filed against Ortho-McNeil Pharmaceutical, Inc., a division of
Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 34 year-old woman. The woman was diagnosed with a severe pulmonary embolism after using the Ortho Evra birth control patch less than two years. The suit was filed in the United States District Court for the District of New Jersey earlier this month.
18 Oct, 2006 5:06 pm
Users of the Ortho Evra birth control patch are cautioned to consult with their physicians about ongoing usage of this drug. The manufacturer
of this patch, Ortho-McNeil Pharmaceutical Inc, lists many potential side effects to be
aware of.
26 Aug 9:20 am
ORTHO-MCNEIL PHARMACEUTICAL v. TEVA is a patent law appeal from a D NJ order granting summary
judgment of invalidity based on anticipation and obviousness, related to the drug ... § 103 likely bars its patentability." KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 417
(2007). Here, the removal of pentobarbital sodium ... found claim 6 to be obvious. [For these reasons, we agree with the district court that Ortho has failed to raise a genuine dispute of material fact regarding the obviousness of claim 6 ...
27 Aug 3:43 am
... patent obvious and anticipated, and granted summary judgment in favor of the defendants. Ortho appealed. Obviousness of combining only
acetaminophen and tramadol The Federal Circuit stated ... reference discloses is a question of fact. Para-Ordnance Mfg., Inc. v. SGS Imps. Int'l, Inc., 73 F.3d 1085, 1088
(Fed. Cir ... relief, the claimed invention is the epitome of obviousness. I therefore respectfully dissent. Ortho-McNeil Pharmaceutical, Inc. ("Ortho") did not invent acetaminophen and it did not invent ...
22 Jan, 2007 7:41 am
... other ratios. Also relevant is the prosecution history of the '691 patent and the '221 reissue patent, described above. Ortho admitted that
it claimed more than it was entitled to claim in the '691 patent when, in its reissue application, it cancelled the broader "comprising" ... reasons, we conclude that the district court
properly granted summary judgment of non-infringement in favor of defendant, Caraco Pharmaceutical Laboratories, Ltd., and against plaintiff, Ortho-McNeil Pharmaceutical, Inc.
2 Sep 5:57 pm
... Property Watch) Ultracet (Tramadol/Acetaminophen) - US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) General The tragedy of a bad
... 'Tarceva' petition (Spicy IP) Taxotere (Docetaxel) - US: Aventis files patent infringement suits against Sun Pharmaceutical in response to Para IV challenge (Patent Docs)
Thalomid (Thalidomide) - Should patient suggestion for treatment be compensated?: ...
19 Jul, 2007 1:47 pm
... .13 (4th Cir. 1984) (applying South Carolina law); Adamson v. Ortho-McNeil Pharmaceutical,
Inc., 461 F. Supp.2d 496, 504 (D.N.J. ... See also Id. at *26 (excluding testimony about ethics in clinical trials). The court cited a couple of pharmaceutical standbys
for this conclusion: In re Rezulin Products Liability Litigation, 309 F. Supp.2d ... 're never too old to learn. The court doesn't cite any other pharmaceutical cases that
excluded foreign regulatory standards, so that suggests we are not alone in ...
13 May 1:52 am
... â€" $5.9 million after taxes â€" in a settlement with Buchanan Ingersoll." MASS-TORT PLAN SOUGHT FOR SUITS OVER ORTHO-MCNEIL'S LEVAQUIN "Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment to their
suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical
Inc. Levaquin is prescribed for bacterial infections of the respiratory system, urinary tract and skin. In July 2008, ...
26 May 2:13 pm
... a May 13, 2009 Law.com article, "Levaquin Tendon Injury Mass Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin": Users of Levaquin, an antibiotic linked to muscle ailments, are asking the New Jersey Supreme Court to accord mass-tort treatment
to their suits against the manufacturer, Johnson & Johnson subsidiary Ortho-McNeil
Pharmaceutical Inc. Acting Administrative Director of the Courts Glenn Grant made the application public in a notice to the Bar ...
6 Oct 10:44 am
... of tendon ruptures, 258 cases of tendonitis, and 274 cases of other tendon disorders associated with the drug sold by Ortho-McNeil Pharmaceutical, Inc. From January 2006 through March 2007, the FDA received 74 additional reports of tendon ruptures, for a total of 336
reported cases. In 2008, the FDA forced Ortho-McNeil to place a Black Box warning on the label of
Levaquin regarding its link to tendon damage, the strongest warning the FDA will ...
15 Jan, 2008 3:06 am
... 07 closed 10/02/07 1:07-cv-04050 Ortho-McNeil Pharmaceutical, Inc. v. Apotex,
Inc. filed 07/18/07 1:07-cv-04062 ... 07 1:07-cv-04512 Technology Development and Licensing, LLC v. Motorola, Inc filed 08/09/07 1:07-cv-04552 McKlein Company LLC v ...
-cv-04709 International Securities Exchange , LLC v. Chicago Board Options Exchange, Inc. filed 08/20/07 1:07-cv-04729 Niro, Scavone, Haller ... 1:07-cv-06293 Nalco Company v.
Enviro Tech Chemical Services, Inc. filed 11/06/07 1:07-cv-06297 Connetics Corporation et ...
Search on: Blawgs.FM | BlawgSearch Google
Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!